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Abstract
Background: The prevalence and burden of disease resulting from obesity have increased worldwide. In Brazil,
more than half of the population is now overweight. However, the impact of this growing risk factor on disease
burden remains inexact. Using the 2017 Global Burden of Disease (GBD) results, this study sought to estimate
mortality and disability-adjusted life years (DALYs) lost to non-communicable diseases caused by high body mass
index (BMI) in both sexes and across age categories. This study also aimed to describe the prevalence of
overweight and obesity throughout the states of Brazil.
Methods: Age-standardized prevalence of overweight and obesity were estimated between 1990 and 2017. A
comparative risk assessment was applied to estimate DALYs and deaths for non-communicable diseases and for all
causes linked to high BMI.
Results: The prevalence of overweight and obesity increased during the period of analysis. Overall, age-
standardized prevalence of obesity in Brazil was higher in females (29.8%) than in males (24.6%) in 2017; however,
since 1990, males have presented greater rise in obesity (244.1%) than females (165.7%). Increases in prevalence
burden were greatest in states from the North and Northeast regions of Brazil. Overall, burden due to high BMI also
increased from 1990 to 2017. In 2017, high BMI was responsible for 12.3% (8.8–16.1%) of all deaths and 8.4% (6.3–
10.7%) of total DALYs lost to non-communicable diseases, up from 7.2% (4.1–10.8%), and 4.6% (2.4-6.0%) in 1990,
respectively. Change due to risk exposure is the leading contributor to the growth of BMI burden in Brazil. In 2017,
high BMI was responsible for 165,954 deaths and 5,095,125 DALYs. Cardiovascular disease and diabetes have proven
to be the most prevalent causes of deaths, along with DALYs caused by high BMI, regardless of sex or state.
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Conclusions: This study demonstrates increasing age-standardized prevalence of obesity in all Brazilian states. High
BMI plays an important role in disease burdens in terms of cardiovascular diseases, diabetes, and all causes of
mortality. Assessing levels and trends in exposures to high BMI and the resulting disease burden highlights the
current priority for primary prevention and public health action initiatives focused on obesity.
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Background
The overall disease prevalence and burden related to
obesity have increased worldwide. The prevalence of
obesity showed a continuous increase between 1980 and
2015 and doubled in 73 countries during this same
period [1, 2]. This increase is more often observed in
low- and middle-income countries, and, in some nations,
it is more prominent among women [3].
A high body mass index (BMI) is one of the major
causes of several diseases worldwide, constituting an im-
portant risk factor for cardiovascular diseases (CVDs)
[4], type 2 diabetes mellitus [4], and neoplasms [5],
among others. It is also associated with many musculo-
skeletal disorders, such as arthritis [6]. Globally, four
million deaths and the loss of 120 million disability-
adjusted life years (DALYs) were attributable to high
BMI in 2015 [2]. Moreover, BMI has proven to be a
feasible indicator of adiposity [7] and is widely used in
epidemiological studies, especially those which assess
time trends in various populations and subgroups.
In Brazil, more than half of the population is over-
weight [8, 9]. The prevalence of obesity was generally
higher among women and has been rising quickly in risk
factor rankings [10]. However, the impact of the rise in
BMI causing disease burdens remains unknown and
should be more specifically assessed in order to better
address this problem. To the best of our knowledge, no
prior studies have estimated the potential effect of
weight gain outcomes in Brazil and their impacts on
those diseases, nor have they analyzed well-known con-
ditions associated with an excess of weight, such as non-
communicable diseases (NCDs).
In parallel, there is an important gap in national
or subnational estimates, which would allow one to
better evaluate public policies concerning health pro-
motion and healthy weight management. Disease
burden estimates attributable to a given risk factor
could be assessed by using a model design of com-
parative risk assessment [11]. This model allows one
to quantify the number and proportions of deaths
and DALYs lost due to non-communicable disease,
which would have been prevented if the risk factor—
in this specific case of high BMI—had been main-
tained at ideal levels [12].
Considering this scenario, using the 2017 national and
subnational Global Burden of Disease (GBD) study re-
sults, the present study aimed to estimate the number
and proportion of deaths and DALYs of non-
communicable diseases caused by high BMI in both
sexes and across age categories. This study also aimed to
describe trends in the prevalence of overweight and
obesity throughout the states of Brazil.
Methods
Global Burden of Disease (GBD) estimates
This study used estimates from the Institute for Health
Metrics and Evaluation (IHME) for Brazil, as reported in
the 2017 GBD study. Brazilian data used by IHME were
provided by the Brazilian Ministry of Health and the
Brazilian Institute of Geography and Statistics (IBGE).
Estimates are available to the public and can be accessed
at http://vizhub.healthdata.org/gbd-compare.
The Global Burden of Diseases, Injuries, and Risk Fac-
tors study provides the most recent epidemiological data
according to year, age, and sex from 195 countries and
territories, including Brazil [13]. Annually, it formulates
an up-to-date comprehensive assessment of the evidence
for national and subnational risk factor exposures and
the main causes of the disease burden [13, 14].
Data sources resulted from a systematic analysis of
published studies and available data sources. BMI data
sources were gathered from multi-country survey pro-
grams, national surveys, and longitudinal studies, which
were available in the Global Health Data Exchange
(GHDx), which can be accessed at http://ghdx.health-
data.org/. In Brazil, BMI data were extracted from
published papers, the National Health Survey [15], the
Consumer Expenditure Survey (POF) [16], the
Telephone Survey Surveillance System for Risk and
Protective Factors for Chronic Diseases (Vigitel) [8],
local surveys, and birth cohorts.
After adjusting for self-report bias and splitting aggre-
gated data into 5-year age-sex groups, the spatiotempo-
ral Gaussian process regression (ST-GPR) was used to
estimate the prevalence of overweight and obesity [13,
17]. This modeling approach has been previously de-
scribed in detail [17].
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Definition of High BMI
The level of exposure that is associated with the lowest
risk is called the theoretical minimum risk exposure
level (TMREL). The TMREL is used to calculate what
could be prevented in the burden of disease if, in the
past, the population exposure would have been sustained
at a theoretical minimum risk of exposure [10, 13].
The TMREL of BMI was determined based on the
BMI level, which was associated with the lowest risk of
all-cause mortality in prospective cohort studies. From
the 2015 GBD on, based on the findings of the most re-
cently pooled analysis of prospective cohorts [18], a BMI
change in the TMREL, from 21–23 to 20–25 kg/m2,
occurred in adults, a cutoff that remained in the 2017
estimates [13, 14, 17].
Population attributable fraction (PAF)
The population attributable fraction (PAF) estimates the
reduction of a determined health metric, such as the
number and proportions of deaths or DALYs in a spe-
cific case scenario, where the optimal level of exposure
(TMREL) would be compared to the altered level of the
same risk factor, through the PAF formula [19, 20] for a
continuous risk factor, as explained elsewhere [17].
Thus, the formula includes the relative risk per 5-unit
change in BMI for each disease endpoint. In this case,
the range of 20–25 km/m2 was assumed to be optimal
when the mortality or morbidity risks were the lowest in
the adult population [17, 18].
Moreover, GBD methodology includes four key com-
ponents in the estimation of the burden attributable to a
given risk factor: (1) the metric of burden being assessed
(the number of deaths, years of life lost [YLLs], years
lived with disability [YLDs], or DALYs [the sum of YLLs
and YLDs]); (2) the exposure levels for a risk factor; (3)
the relative risk of a given outcome due to exposure; and
(4) the counterfactual level of risk factor exposure [13,
14]. All modeling is performed using a Bayesian meta-
regression model (DisMod-MR 2.1) [13, 17].
Data analysis
This study first analyzed estimates of age-standardized
prevalence and its 95% uncertainty interval (95%UI) of
overweight (BMI ≥ 25.0 kg/m2) and obesity (BMI ≥ 30
kg/m2) for the adult population of 20 years old and older
between 1990 and 2017, in both sexes and across states.
The percent change in prevalence from 1990 to 2017,
with its uncertainty intervals, was then assessed.
Second, the portion of death and DALY rates that
could be attributable to high BMI in 2017 for all causes,
and mostly for non-communicable diseases, including
CVDs, diabetes, chronic kidney diseases, and neoplasms,
was analyzed. All estimates were extracted according to
age, sex, and states.
Third, this study analyzed the trends of mortality and
DALY rates attributable to high BMI in the period from
1990 to 2017, for men and women. Also, evaluated were
the decomposition of the percent changes (1990–2017)
in death and DALY rates attributed to the high BMI
found in four factors: (1) population growth, (2) popula-
tion age structure, (3) risk-deleted DALY rates, and 4)
high BMI exposure [13, 17, 21]. In summary, risk-
deleted rates are death and DALY rates that would have
been observed if the high BMI risk factor had been re-
duced to the TMREL levels, multiplied by one minus
PAF. The methodology adopted by the GBD study also
produces linear risk-aggregates over time and is de-
scribed elsewhere in more detail [13, 17, 21].
The GBD’s world population age standard has been
described elsewhere [22]. The GBD Brazil study was
approved by the Research Ethics Committee of
Universidade Federal de Minas Gerais (UFMG)
(CAAE—62803316.7.0000.5149).
Results
Table 1 shows adult age-standardized prevalence for the
adult population of 20 years old and older, with 95% un-
certainty intervals (UI) of overweight (BMI ≥ 25.0Kg/m2)
in Brazil and its federal units, determined according to
sex. In 2017, overall prevalence was 54.3% (95% UI
52.0–56.6) for men and 52.4% (95% UI 49.8–55.0) for
women, showing no statistically significant difference by
sex. More than half of the population was overweight in
Brazil in most states, except for Maranhão and Piauí.
The states with prevalence above the national rate were,
in decreasing order of importance, Distrito Federal (73.8
and 70.4%), Mato Grosso do Sul (58.4 and 54.5%), Rio
Grande do Sul (57.8 and 54.1%), Mato Grosso (57.2 and
53.9%), Paraná (56.4 and 52.7%), São Paulo (56.2 and
53.4%), Acre (55.6 and 55.8%), Rio de Janeiro (55.6 and
52.4%), Roraima (54.8 and 54.0%), Amazonas (54.7 and
57.0%), and Ceará (54.6 and 53.4%) for both men and
women, respectively; Amapá (56.3%), Rondônia (53.2%),
Rio Grande do Norte (52.9%), and Pernambuco (52.5%)
for women only, and Santa Catarina (56.2%) for men
only. This table also shows the percent change in preva-
lence in the period from 1990 to 2017. A similar in-
crease for men, 47.6% (95%UI 36.4–59.8), and women,
47.6% (95%UI 34.6–61.3), as observed. This increase was
above 50% in most of the federated units and above 70%
in most of the Northern and Northeastern states, and
was most commonly found in women.
This same table shows the adult age-standardized
prevalence of obesity (BMI ≥ 30.0 kg/m2), which was
higher among women, 29.8% (95%UI 27.9–31.8), than
among men, 24.6% (95%UI 22.8–26.5). An increased
prevalence for both sexes was observed in Acre,
Amazonas, Amapá, Distrito Federal, Mato Grosso do
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Table 1 Overweight (BMI ≥ 25.0 Kg/m2) and obesity (BMI ≥ 30.0 kg/m2) adult age-standardized prevalence in 2017 and percent
change (APC) and 95% uncertainty intervals from 1990 to 2017 for Brazil and 27 states







Percent change in obesity
prevalence, 1990–2017
% 95% UI % 95% UI % 95% UI % 95% UI
Brazil Male 54.3 52.0–56.6 47.6 36.4 -59.8 24.6 22.8–26.5 244.1 196.3–302.3
Female 52.4 49.8–55.0 47.6 34.6–61.3 29.8 27.9–31.8 165.7 133.8–202.6
Acre Male 55.6 52.4–58.8 76.8 54.4–103.2 24.8 22.4–27.5 338.2 246.4–450.0
Female 55.8 52.1–59.5 74.2 48.8–102.1 32.0 28.9–35.0 251.9 187.7–331.8
Alagoas Male 51.9 48.8–55.2 85.6 62.5–113.3 21.2 19.0–23.7 354.4 258.8–491.2
Female 50.6 47.1–54.1 87.1 61.6–118.9 28.0 25.6–30.9 270.3 207.6–362.1
Amazonas Male 54.7 51.5–57.7 51.5 34.0–71.7 26.8 24.1–29.8 274.8 197.4–370.6
Female 57.0 53.1–60.7 67.5 44.6–95.2 32.4 29.4–35.4 200.5 148.4–264.7
Amapá Male 54.2 50.9–57.4 71.2 49.9–95.6 25.9 23.1–28.7 315.8 228.7–423.5
Female 56.3 52.5–60.0 81.9 54.9–111.9 32.2 29.3–35.3 255.5 191.1–338.2
Bahia Male 47.8 44.9–50.8 64.3 45.2-–89.1 18.5 16.6–20.5 277.8 200.2–374.3
Female 51.4 47.7–54.7 70.3 46.6–97.7 27.8 25.3–30.5 217.0 157.9–290.4
Ceará Male 54.6 51.4–58.0 70.0 49.9–92.5 24.9 22.3–27.5 310.4 227.0–415.8
Female 53.4 49.8–57.1 79.0 54.8–108.8 29.4 26.8–32.1 247.7 184.1–329.0
Distrito Federal Male 73.8 69.5–78.0 27.1 13.3–42.5 48.0 43.4–52.7 185.3 130.8–255.0
Female 70.4 65.8–75.5 31.9 15.7–50.3 51.9 47.4–57.1 126.4 89.3–170.7
Espírito Santo Male 53.9 50.8–57.1 46.0 27.8–67.4 23.4 21.1–26.0 229.8 165.2–311.1
Female 51.7 48.1–55.3 59.2 37.3–85.8 29.0 26.1–31.8 187.6 135.9–250.9
Goiás Male 52.9 50.0–56.0 58.7 39.0–80.8 21.4 19.3–23.8 271.0 195.3–367.1
Female 51.1 47.7–54.7 60.3 39.2–86.6 28.4 25.8–31.0 205.1 149.6–271.6
Maranhão Male 47.1 44.2–50.3 88.3 64.2–119.0 16.9 15.1–18.9 372.2 266.8–518.4
Female 47.2 43.8–50.6 96.6 67.6–130.3 23.8 21.6–26.0 297.2 220.5–396.1
Minas Gerais Male 51.5 48.5–54.5 54.6 36.4–74.8 21.3 19.3–23.4 243.3 179.0–320.9
Female 50.0 46.8–53.5 23.5 8.7–42.1 27.0 24.7–29.4 112.1 77.7–156.4
Mato Grosso do Sul Male 58.4 54.9–61.6 66.8 46.6–89.2 27.0 24.4–29.8 301.1 222.5–400.8
Female 54.5 51.0–58.1 71.0 48.5–96.4 31.7 29.1–34.6 235.6 176.8–310.0
Mato Grosso Male 57.2 54.1–60.7 52.7 35.6–72.8 25.6 23.1–28.5 242.3 174.0–327.9
Female 53.9 50.4–57.5 53.1 32.7–77.2 30.5 27.6–33.5 182.6 134.5–247.2
Pará Male 53.6 50.6–56.7 59.4 40.6–83.5 22.7 20.2–25.1 248.3 174.4–338.5
Female 50.7 47.3–54.0 75.7 51.4–106.4 26.1 23.8–28.7 219.7 158.9–294.2
Paraíba Male 52.6 49.5–55.8 50.6 32.8–70.4 22.9 20.5–25.5 231.2 164.1–318.1
Female 50.6 47.2–53.9 54.4 33.1–78.1 27.0 24.5–29.7 178.8 128.8–239.2
Paraná Male 56.4 53.3–59.8 50.6 34.0–72.2 24.7 22.3–27.3 253.9 184.1–343.6
Female 52.7 49.5–56.3 51.9 32.1–74.4 29.1 26.7–31.7 172.7 128.9–230.7
Pernambuco Male 52.1 49.4–55.2 55.3 37.7–78.2 22.1 20.0 –24.6 258.2 191.2–353.0
Female 52.5 49.2–56.0 61.1 39.5–85.2 27.5 25.1–30.0 191.8 141.3–252.6
Piauí Male 47.7 44.6–50.8 76.8 54.6–105.0 18.6 16.5 –20.9 313.9 227.9–432.7
Female 46.8 43.5–50.4 79.9 55.1–109.9 23.9 21.6–26.4 245.4 180.5–333.1
Rio de Janeiro Male 55.6 52.2–58.7 32.9 17.8–49.5 28.4 25.6 –31.5 225.1 164.1–302.7
Female 52.4 48.9–55.6 33.8 17.2–54.1 32.2 29.6–35.0 141.3 101.3–188.6
Rio Grande do Norte Male 53.5 50.4–56.7 64.9 43.1–90.8 24.4 21.8–27.1 292.3 206.6–398.1
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Sul, Mato Grosso, Rio Grande do Sul, Rio de Janeiro,
and São Paulo. By contrast, an increased prevalence only
among women was found in Rondônia and Roraima, as
compared to Paraná, Ceará, and Santa Catarina where
the prevalence was found mostly among men. The per-
cent change in obesity prevalence from 1990 to 2017
was 244.1 (95% UI 196.3–302.3) for men and 165.7 (95%
UI 133.8–202.6) for women. An annual increase of over
300% was observed in most of the North and Northeast
states for men. Trends of overweight and obesity during
this same period were accessed and are presented in an
additional file (supplementary Figure 1).
Regarding the disease burden, overall, in 2017, high
BMI was responsible for an estimated 12.3% of total
deaths and 8.4% of total DALYs for all causes. Thus, this
risk factor was responsible for 165,954 deaths and 5,095,
125 DALYs. High BMI attributable deaths and DALYs
were more important in women (14.6%, 95% UI 10.7–
18.9 and 9.4%, 95% UI 7.2–11.7, respectively) than in
men (10.5%, 95% UI 7.2–14.1 and 7.7%, 95% UI 5.5–
10.0, respectively). Specifically, 16.2% (95% UI 11.6–
221.1) of deaths and 11.9% (95%UI 8.8–15.1) of DALYs
due to non-communicable diseases were attributable to
high BMIs, but no statistically significant differences
were observed between the sexes.
CVDs and diabetes, followed by neoplasms, chronic
kidney diseases, and neurological disorders, for both
sexes, were the leading causes through which high BMI
acts to cause disease burdens (Fig. 1). This same graph
shows differences between the sexes, such as death rates,
which were more prominent among women, particularly
for diabetes and neurological disorders, and DALYs,
which were higher among men, including CVDs and
neoplasms. However, when considering the uncertainty
intervals, no statistically significant difference was ob-
served (supplementary Table 1). The same occurred
among women, as high BMI also proved to be more as-
sociated with DALY rates of musculoskeletal disorders,
whereas the UIs overlapped.
Approximately, 96,347 deaths occurred due to CVDs
resulting from high BMIs in 2017, which represents 7.1%
of all deaths, as compared to 2,605,648 DALYs, repre-
senting 4.3% of all DALYs.
Figure 2 shows death and DALY rates related to BMI in
both sexes and across age categories. Death rates for dia-
betes and CVDs caused by high BMI begin to increase
after 40 years of age, whereas neoplasms begin to increase
after 50 years of age and neurological disorders after 60
years of age, for both sexes. As for DALYs, an early onset
of these burdens was noticed at around 30 years of age
due to CVDs, diabetes, and urogenital, blood, and endo-
crine diseases, and at around 40 years of age for musculo-
skeletal diseases, for both sexes. Regarding neoplasms, a
statistically significant difference was observed between
the sexes, which increased considerably after 35 years of
age among men and after 50 years of age among women.
Table 1 Overweight (BMI ≥ 25.0 Kg/m2) and obesity (BMI ≥ 30.0 kg/m2) adult age-standardized prevalence in 2017 and percent
change (APC) and 95% uncertainty intervals from 1990 to 2017 for Brazil and 27 states (Continued)







Percent change in obesity
prevalence, 1990–2017
% 95% UI % 95% UI % 95% UI % 95% UI
Female 52.9 49.3–56.8 75.4 52.4–105.6 28.3 25.8–31.1 238.6 177.6–318.0
Rondônia Male 53.8 50.2–56.9 68.5 47.6–92.6 24.1 21.7–26.8 293.6 211.6–397.3
Female 53.2 49.8–56.9 69.6 46.9–96.2 30.1 27.2–33.0 216.0 158.9–287.8
Roraima Male 54.8 51.8–58.0 64.5 43.7–88.7 23.7 21.2–26.6 281.9 201.2–383.5
Female 54.0 50.3–57.7 71.8 48.0–98.9 30.1 27.5–32.8 222.0 166.5–291.4
Rio Grande do Sul Male 57.8 54.7–60.8 38.5 23.0–56.5 25.5 23.1–28.1 207.1 149.9–278.4
Female 54.1 50.8–57.6 43.1 24.7–63.1 32.5 29.8–35.7 150.4 109.1–201.8
Santa Catarina Male 56.2 52.9–59.7 38.3 22.6–56.2 25.3 22.7–27.9 227.7 162.3–313.2
Female 50.4 47.4–54.0 45.9 27.7–67.3 28.3 25.9–31.1 152.2 108.0–208.0
Sergipe Male 52.9 49.6–56.3 66.8 46.5–91.1 24.0 21.6–26.7 305.0 224.5–409.2
Female 51.1 47.7–54.5 65.9 42.9–92.7 28.5 25.9–31.2 208.6 151.1–283.8
São Paulo Male 56.2 53.3–59.1 35.3 22.3–50.4 27.7 25.1–30.4 231.1 173.5–298.7
Female 53.4 50.0–56.6 36.9 21.4–54.5 31.8 29.2–34.4 149.3 112.3–192.8
Tocantins Male 51.9 49.0–54.8 74.6 52.0–100.9 20.4 18.1–22.7 311.1 222.2–422.3
Female 49.2 45.9–52.6 83.8 57.0–117.0 26.5 24.1–29.1 259.5 191.9–342.8
95% UI 95% uncertainty intervals, BMI body mass index
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Moreover, Fig. 3 shows DALY and death rates
caused by high BMI across all Brazilian states accord-
ing to sex in 2017. Some states, such as Alagoas, Per-
nambuco, and Rio de Janeiro, present a higher
burden attributable to high BMIs than the average re-
ported in Brazil, with higher death rates due to CVDs
and diabetes mellitus. A higher death rate due to
neurological disorders was observed in the Federal
District of Brasília, more deaths due to neoplasms
among women in Roraima, and higher death rates
due to CVDs among men in Mato Grosso do Sul, all
attributable to high BMI. It was observed that these
same states have higher rates of DALYs attributable
to high BMIs, although differences are non-significant
when considering the 95% UI (supplementary Table
1) (Fig. 3b).
Figure 4 shows that the crude death rates attributable
to high BMI increased 61.4% and 57%, for men and
women, respectively, between 1990 and 2017, from 46.9
(UI 95% 24.8–72.7) and 45.4 (27.5–65.7) deaths per 100,
000 in 1990 to 76.4 (UI 95% 52.1–103.1) and 80.2 (58.7–
103.3) deaths per 100,000 in 2017. In this same period,
the crude DALY rates rose 51% and 53%, for men and
women, respectively, from 1647.6 (UI 95% 904.6–2477.6)
and 1517.2 (95% UI 956.6–2157.2) per 100,000 in 1990
to 2485.7 (95% UI 1772.6–3259.5) and 2328.8 (95% UI
1770.4–2926.7) per 100,000 in 2017. When these rates
were age-standardized, relatively stable curves are
observed.
At last, Fig. 5 shows decomposition of percent changes
in all-cause deaths and DALY numbers related to high
BMIs from 1990 to 2017. For deaths, the change due to
population aging was responsible for 122% of the in-
crease, while the change in risk exposure accounted for
125% and population growth was responsible for 42%,
and the change in risk-deleted rates was responsible for
a decrease of 149%. The change due to population aging
contributed to an increase of 137% and 109% for women
and men, respectively, an increase of 26% in females. In
terms of DALYs, for both sexes, population aging
accounted for an increase of 96%, changes in risk expos-
ure increased by 130%, while 42% was due to population
growth. On the other hand, the change in risk-deleted
rates decreased by 152%.
Fig. 1 Death (a) and DALY (b) rates per 100,000 attributable to High BMI by sex, Brazil, 2017. Legend: Deaths (a) and DALY (b) rates per 100,000
of non-communicable diseases related to high BMI are shown for males and females. Numbers in the x-axis represent the rates. DALYs, disability-
adjusted life-years; BMI Body mass index
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Discussion
The present study demonstrates an increasing age-
standardized prevalence of overweight and obesity in the
Brazilian adult population and states from 1990 to 2017.
The overall age-standardized prevalence of obesity in
Brazil was higher in females than males in 2017, but
males presented a higher increase than did females dur-
ing the same period. The percent change was higher in
the Northern and Northeastern states, which, for the
most part, are less developed and lower income regions.
This increase has been observed in previous national
surveys [8, 23–26] and among children and adolescents
[27]. Similar results were found when comparing coun-
tries of different income levels, where there was an in-
crease in people’s excess of weight in low- and middle-
income countries (LMIC), while lower levels were
observed in rich nations [3, 28]. This implies the persist-
ence of malnutrition, but now in the form of overnutri-
tion rather than undernutrition [3, 25].
Drivers of this phenomenon have been described in
detail in previous studies, such as changes in the food
environment, greater supply of high energy foods, mar-
keting, urbanization, and the built environment, which
have also cut down time and space for physical activities
Fig. 2 Death (a) and DALY (b) rates per 100,000 of specific causes attributable to high BMI according to age and by sex. Brazil, 2017.
Legend: Death (a) and DALY (b) rates per 100,000 related to high BMI are shown for females (dotted line) and males (full line) and across age
categories. Each line is a specific cause attributable to high BMI. The y-axis has the death (a) and DALY (b) rates and the x-axis the age categories.
DALYs, disability-adjusted life-years; BMI, body mass index
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[2, 29–31]. Moreover, as a metabolic condition, high
BMI is an intermediary risk factor in the causal
model of NCDs, which is usually a consequence of
other important risk factors, such as inadequate diet
and physical inactivity, which have also proven to
have reached levels in Brazil that are even higher
than those of high BMIs [10, 32].
Therefore, high BMI exposure is increasing and driv-
ing up its attributable burden throughout Brazil, corrob-
orating global findings for this specific risk factor [2, 13,
14, 17]. Our study shows that high BMI played an im-
portant role in the national burden (deaths and DALYs)
of NCDs, especially those related to CVDs and diabetes
mellitus.
Prior studies have shown a relationship between excess
weight and mortality for all causes in the four continents
[18]. The present study has more specifically shown the
burden of NCDs due to this condition, as well as esti-
mates of DALYs due to excess weight. The present study
results are similar to those found for the Eastern
Mediterranean countries [33]. Furthermore, more than
60% of overweight individuals live in LMICs, and, in
these settings, the relationship of high BMI and morbid-
ity has also been understudied [34].
Fig. 3 Age-standardized Death (a) and DALY (b) rates per 100,000 attributable to high BMI across all states by sex, women on the left and men
on the right. Legend: Colored bars are the attributable age-standardized DALY and death rates corresponding to high BMI, each color a specific
cause, across all Brazilian states, 2017. Women are on the left and men on the right. DALYs, disability-adjusted life-years; BMI, body mass index
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The attributable fraction of NCD burden due to high
BMI revealed no sex-specific pattern. Although death
rates were more prominent among women, particularly
for diabetes mellitus and neurological disorders, and
DALYs were higher among men when considering CVD
and neoplasms, uncertainty intervals overlapped. Never-
theless, it is important to note that NCDs have proven
to be responsible for the greatest burden of death and
disability among women, highlighting CVD, diabetes
mellitus, dementia, depression, and musculoskeletal dis-
orders [35]. As such, the prevention of NCDs should be
more advocated for women, as the healthcare agenda for
women commonly gives priority to sexual and repro-
ductive health issues. Our study results indicate that an
important part of this burden is due to high BMIs.
Moreover, a recent study has also shown a greater in-
crease in obesity prevalence among Brazilian women of
childbearing age [23], which are relatively young women.
Moreover, a considerable number of premature deaths
have been observed due to CVDs caused by high BMIs
among men of young ages, which might contribute to
higher DALY rates, as observed through the YLL com-
ponent of this measurement.
Mechanisms underlying the consequences of obesity
leading to NCDs have also been explained in previous
reports, especially regarding CVD and DM [36–38].
High BMI mostly causes a chronic systemic inflam-
mation and higher sympathetic activity, which can
Fig. 4 Trends of mortality (a) and DALY (b) rates, all ages and age-standardized attributable to high BMI by sex, 1990-2017, Brazil. Legend: Crude
and age-standardized deaths and DALY rates attributable to high BMI, by sex, are shown. Y-axis presents the rates and x-axis the years. The line
shows the trends in the period of 1990–2017. DALYs, disability-adjusted life-years; BMI, body mass index
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contribute to insulin resistance and hypertension, re-
spectively [37], leading to endothelial dysfunction and
atherosclerosis [38]. Thus, its effect is primarily medi-
ated through other intermediary risk factors, such as
hypertension, hypercholesterolemia, and hypergly-
cemia, the last two also known as metabolic risk fac-
tors [37]. Recent evidence also highlights the relation
between obesity and neurological disorders in the hip-
pocampal structure and function [39]. The present
study observed a higher burden of neurological disor-
ders due to high BMIs among individuals of 60 years
old and older.
The overall burden due to high BMI increased from
1990 to 2017. When considering the decomposition of
Fig. 5 Decomposition of deaths (a) and DALYs (b) attributable to high BMI, Brazil 1990-2017. Legend: Percent change in risk-attributable deaths
and DALYs. Results are shown for all causes combined. The black dot shows total percentage change. The risk-deleted DALY rate is the expected
DALY rate if the exposure level for high BMI was reduced to the theoretical minimum risk exposure level. DALYs, disability-adjusted life-years; BMI,
body mass index
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percent changes in all-cause DALYs and deaths related
to this specific risk in the studied period, high BMI
trends in attributable mortality and DALYS are driven
by the interplay between population aging, an increase
in risk exposure, and population growth. Moreover,
change due to risk exposure is the leading contributor to
growth in overweight and obesity burden in Brazil,
followed by population aging, rather than the population
growth, which had a lesser contribution. This under-
standing of drivers is crucial to subsidize public policies
and interventions.
To the best of our knowledge, these are the first national
and subnational estimates of these two metrics of the bur-
den of NCDs attributable to high BMIs in Brazil. The in-
creased in NCDs in Brazil is a great challenge, and to
tackle it, its main risk factors, such as high BMI, must be
addressed. The subnational approach is an important ad-
vance, as it allows for the evaluation of important dispar-
ities within the country and helps in the creation of local
policies adjusted to the reality of each setting.
Thus, the present study advances this matter, and its
findings are crucial for the development of an approach
to public health, including the renewal of surveillance,
management, and prevention policies in Brazil. Public
policies, like the “Strategic Actions Plan for Coping with
NCDs in Brazil, 2011-2022” [40], have been of great use
in guiding surveillance at the national level of NDCs and
their risk factors, such as high BMI, but further advances
through interventions are required.
Since 2011, various polices have been established to
address this problems in Brazil [39, 41, 42], but no major
population success has yet been shown, corroborating a
scenario found for other nations as well [2]. Thus, des-
pite of this great challenge, it represents an opportunity
to tackle disease burdens, especially considering the fact
that developed countries have made some progress in fa-
cing overweight [3].
Moreover, promoting healthier individual lifestyles, fo-
cused on diet and physical activity strategies and inter-
ventions, is necessary, especially in Northern and
Northeastern states, but it is not enough. New
approaches should consider measures that take into
account the patient’s entire lifespan [43], such as inter-
generational cycles and focus on childhood [44].
Healthcare providers should be more aware of simple
measures in primary health care. Height and weight can
be easily accessed, followed by a simple calculation of
BMI, which could detect an important risk factor for
greater health burdens, including death. On the other
hand, weight loss could act directly in the reduction of
incidences of many diseases, such as diabetes mellitus
[45] and CVD [46].
This study has limitations, which should be consid-
ered. First, GBD used both self-reported and measured
data with respect to height and weight. On the other
hand, GBD methodology corrected the bias in self-
reported data, using measured data for each age, sex,
and geographic region, as previously described [17].
High agreement between measured and self-reported an-
thropometric data was demonstrated, using several stat-
istical methods across sex, age group, education level,
and household location categories, which reinforces their
use as proxies of measured values in the Brazilian popu-
lation ≥ 18 years old [47]. Moreover, GBD methodology
and estimates have been used worldwide and approved
as valid in several countries.
Estimates before 2000 should be more carefully con-
sidered, as national surveys monitoring this risk factor
were less frequently applied. Furthermore, a possible im-
pact of pre-existing diseases and other confounding fac-
tors, such as smoking and other lifestyle habits, cannot
be excluded, which could not be evaluated, but are usu-
ally excluded from the observational studies, which are
sources of relative risk estimation [2]. Moreover, this
limitation should be taken cautiously, as there is a well-
established biological mechanism between adiposity tis-
sue accumulation and metabolic diseases, such as
diabetes [36].
Conclusions
Prevalence of overweight and obesity continues to rise
in the Brazilian population, with some variability
across states and regions. Additionally, the burden of
NCDs associated with high BMI should be considered
high, especially in times when abundant evidence
highlighting obesity as a major risk factor for NCDs
is available. These results signal the need for in-
creased attention to healthcare programs aimed at
maintaining healthy weight in order to tackle the
NCD burden in Brazil.
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